FRK inhibition attenuates aerobic glycolysis in some cancer cell models [23], while studies performed in other cancer cell models suggest FRK inhibition increases proliferation by downregulating the FRK-PTEN axis [252]. This evidence concerns the gene PTEN and cancer.